This nonsystematic review provides a compilation of recent data comparing the efficacy and safety of premixed insulin analogues versus basal insulin analogues used alone or in combination with rapid-acting insulin analogues before meals in patients with T2DM. This evidence concerns the gene INS and type 2 diabetes mellitus.